Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells

Chest

Volumn 111, Issue 6, 1997, Pages 1684-1690

  Narula, Jagat ^a,b   Petrov, Artiom ^a   Pak, Koon Yan ^c   Ditlow, Charles ^c   Chen, Francis ^c   Khaw, Ban An ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c Scotgen Pharmaceuticals Inc   (United States)

Author keywords

Antibody; Atheroma; Radiolabel; Radionuclide imaging; Smooth muscle cell

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; TECHNETIUM 99M;

ANIMAL MODEL; AORTA; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOSCINTIGRAPHY; NONHUMAN; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; VASCULAR SMOOTH MUSCLE;

EID: 0031000311     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.6.1684     Document Type: Article

References (24)

1. Narula J, Carrio I, Khaw BA. Targeting atherosclerotic lesions with monoclonal antibodies. In: Hollinger MA, ed. Torchilin VP, volume ed. Handbook of targeted delivery of imaging agents (CRC series on pharmacology and toxicology). Boca Raton, Fla: Raven Press, 1995, 429-45
2. Narula J, Ditlow C, Chen FW, et al. Monoclonal antibodies for the detection of atherosclerotic lesions. In: Monoclonal antibodies in cardiovascular diseases. Khaw BA, Narula J, Stranss HW, eds. Philadelphia: Lea & Febiger, 1994: 206-15
3. Matsumoto A, Naito M, Itakura H, et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA. 1990; 87:9133-37
4. Thyberg J, Heidin U, Sjolund M, et al. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990; 10:966-84
5. Narula J, Petrov A, Bianchi C, et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric antibody Z2D3 specific for proliferating smooth muscle cells in human atheroma: imaging with conventional antibody and with negative charge modified antibody fragments. Circulation 1995; 92:474-84
6. Narula J, Petrov A, O'Donnell SM, et al. Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in vivo targeting. J Nucl Cardiol 1996; 3:231-41
7. Miller DD, Rivera FJ, Garcia OJ, et al. Imaging of vascular injury with Tc-99in-labeled monoclonal antiplatelet antibody S12: preliminary experience in human percutaneous transluminal angioplasty. Circulation 1992; 85:1354-60
8. Pieri P, Carrio I, Narula J, et al. Imaging of human atherosclerotic lesions with indium-111-labeled Z2D3 antibody specific for proliferating smooth muscle cells of human atheroma. J Am Coll Cardiol 1996; 27:321A
9. 99mTc. Nucl Med Biol 1989; 16:171-76
10. Pettit WA, Deland FH, Bennett SJ, et al. Improved protein labeling by stannous tartrate reduction of pertechmetate. J Nucl Med 1980; 21:59-62
11. Rhodes BA, Zamora PO, Newell KD, et al. Technetium-99m labeling of murine antibody fragments. J Nucl Med 1986; 27:685-93
12. Paik CH, Phan LNB, Hong JJ, et al. The labeling of high affinity sites of antibodies with tc-99m. Int J Nucl Med Biol 1985; 12:3-8
13. Kanellos J, Peitersz GA, McKenie IFC, et al. Coupling of Tc-99m nitrodo group to monoclonal antibody and use of the complexes for the detection of tumor in mice. J Natl Cancer Inst 1986; 77:431-39
14. 99mTc. Nucl Med Biol 1989; 16:11-6
15. Pak KY, Nedelman MA, Kanke M, et al. An instant kit method for labeling antimyosin Fab' with Tc-99m: evaluation in an experimental myocardial infarct model. J Nucl Med 1992; 33:144-49
16. Harrison DO, Calenoff E, Chen FW, et al. Plaque associated immune reactivity as a tool for the diagnosis and treatment of atherosclerosis. Proceedings of the American Clinical and Climabiological Association, October 1991; 210-17
17. Dietrich DR. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 1993; 23:77-109
18. Kocher O, Gabbiani F, Gabbiani G, et al. Phenotypic features of smooth muscle Cells during the evolution of experimental carotid artery intimal thickening: biochemical and morphologic studies. Lab Invest 1991; 65:459-70
19. Habeeb AFSA. Reaction of protein sulfhydryl group with Ellman's reagent. Methods Enzymol 1972; 25:457-64
20. Narula J, Petrov A, Pak KY, et al. Very early noninvasive imaging of acute myocardial infarcts with Tc-99m glucarate [abstract]. J Am Coll Cardiol 1995; 24:218A
21. Soule HR, Linder E, Edgington T. Membrane 126 Kda phosphoglycoprotein associated with human carcinomas identified by hybridoma antibody to mammary carcinoma cells. Proc Natl Acad Sci USA 1983; 80:1332-36
22. Baumgartener HR. Eine neue methode zur erxeugung von thromben durch geziette uberdehnung der gefasswand. Z Gesamte Exp Med 1963; 137:227-49
23. Khaw BA, Strauss HW, Narula J. Magic bullets: from muskets to smart bombs [editorial]. J Nucl Med 1993; 34:2264-68
24. Narula J, Petrov A, Virmani R, et al. Preferential uptake of indium-111-labeled Z2D3 in rapidly proliferating smooth muscle cells envisions clinical utility of Z2D3 in predicting restenosis [abstract]. J Nucl Med 1996; 37:352P